The genome of the Pasteur 17D-204 vaccine strain of yellow fever virus has been cloned into pBR327. The inserts of recombinant plasmids were analysed by restriction cleavage pattern and compared with that of the genome of another substrain previously cloned and sequenced. Ten of the overlapping inserts were found to contain the sequence of the complete genome. We have sequenced approximately 3680 bases of the 5′ region which codes for the C, M and E structural proteins and the NS1 non-structural protein. This sequence is the same as that reported previously, indicating a remarkable stability of these two vaccine substrains.
AuperinD.,
SassoD. R.,
McCormickJ. B.1986; Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology 154:155–167
GrangeT.,
BouloyM.,
GirardM.1985; Stable secondary structures at the 3ʹ-end of the genome of yellow fever virus (17D vaccine strain). FEBS Letters 188:159–163
MonathT. P.,
KinneyR. M.,
SchlesingerJ. I.,
BrandrissM. W.,
BrèsP.1983; Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced worldwide. Journal of General Virology 64:627–637
RiceC. M.,
LenchesE. M.,
EddyS. R.,
ShinS. J.,
SheetsR. I.,
StraussJ. H.1985; Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726–733
SangerF.,
NicklenS.,
CoulsonA. R.1977; DNA sequencing with chain termination inhibitors. Proceedings of the National Academy of Sciences U.S.A.: 745463–5467
World Health Organization1979Procedure for WHO Approval of Yellow Fever Vaccine for Issue of International Vaccination Certificates Report of a WHO Working Group; Geneva:22–24May1979